Attitudes and Usage of the Food and Drug Administration Adverse Event Reporting System Among Gastroenterology Nurse Practitioners and Physician Assistants

Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
Allison Salk, Eli D Ehrenpreis


The Food and Drug Administration Adverse Event Reporting System (FAERS) is used for postmarketing pharmacovigilance. Our study sought to assess attitudes and usage of the FAERS among gastroenterology nurse practitioners (NPs) and physician assistants (PAs). A survey was administered at the August 2012 Principles of Gastroenterology for the Nurse Practitioner and Physician Assistant course, held in Chicago, IL. Of the 128 respondents, 123 (96%) reported a specialty in gastroenterology or hepatology and were included in analysis. Eighty-nine participants were NPs and 32 PAs, whereas 2 did not report their profession. Although 119 (98%) agreed or strongly agreed with the statement that accurately reporting adverse drug reactions is an important process to optimize patient safety, the majority of participants (54% NPs and 81% PAs) were unfamiliar with the FAERS. In addition, only 20% of NPs and 9% of PAs reported learning about the FAERS in NP or PA schooling. Our study shows enthusiasm among gastroenterology NPs and PAs for the reporting of adverse drug reactions, coupled with a lack of familiarity with the FAERS. This presents an opportunity for enhanced education about reporting of adverse drug reactions for gastroenterology NPs...Continue Reading


Jul 1, 1988·Archives of Internal Medicine·A S RogersG Faich
Oct 1, 1995·The Joint Commission Journal on Quality Improvement·D J CullenLucian L Leape
Dec 3, 1999·British Journal of Clinical Pharmacology·I A ElandB H Stricker
Mar 14, 2002·Journal of the American Geriatrics Society·R L KaneT Rockwood
Oct 24, 2002·Journal of Clinical Epidemiology·J HasfordB Müller-Oerlinghausen
Nov 15, 2002·The New England Journal of Medicine·Lucian L Leape
Jan 22, 2003·Journal of General Internal Medicine·Syed Rizwanuddin Ahmad
May 13, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Lorna Hazell, Saad A W Shakir
Sep 12, 2007·Archives of Internal Medicine·Thomas J MooreCurt D Furberg
Jul 10, 2008·Pharmacoepidemiology and Drug Safety·Paula GardinerGabriel I Giancaspro
Oct 23, 2008·Disease-a-month : DM·Alison AtwaterJodi Khouri
Jan 8, 2009·European Journal of Clinical Pharmacology·Marie-Louise JohanssonSusanna M Wallerstedt
Feb 9, 2010·The American Journal of Gastroenterology·Spencer D Dorn
May 5, 2010·Health Affairs·Thomas Bodenheimer, Hoangmai H Pham
Nov 4, 2010·Journal of Interprofessional Care·Perri A MorganNancy M Short
Nov 19, 2010·Postgraduate Medicine·Richard PushkinStephanie Kim
Jan 19, 2012·The Annals of Pharmacotherapy·Greene ShepherdDianne Williams May
Feb 18, 2012·Critical Care : the Official Journal of the Critical Care Forum·David L CarpenterCraig M Coopersmith
May 23, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Behrooz K ShamlooSheila Weiss Smith
Apr 11, 2013·Clinical Pharmacology and Therapeutics·R HarpazN H Shah


Aug 5, 2017·European Journal of Clinical Pharmacology·Caterina Bigi, Guido Bocci

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Related Papers

JAAPA : Official Journal of the American Academy of Physician Assistants
Daisha J CipherE S Sekscenski
JAAPA : Official Journal of the American Academy of Physician Assistants
Ian W Jones
© 2021 Meta ULC. All rights reserved